Return to search

FlowCardia Raises $30 Million

FlowCardia Inc., a Sunnyvale, Calif.-based developer of endovascular devices for coronary and peripheral chronic total occlusion (CTO) recanalization, has raised $30 million in Series C funding. Gilde Healthcare Partners led the round, and was joined by Life Sciences Partners, H&Q Capital Management and New Science Ventures, Rockport Venture Partners and Gold Hill Capital. Return backers included Frazier Healthcare Ventures, JPMorgan Partners and Pappas Ventures. www.flowcardia.com